Analyst consensus rating
Teva Pharmaceutical Industries Analyst Rating: Strong Buy
Direct answer
Teva Pharmaceutical Industries's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $47.58.
Forecast evidence checked October 27, 2026.
Get free Teva Pharmaceutical Industries email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $40.39
- Average price target
- $47.58
- High price target
- $55.00
- Low price target
- $42.00
- Low target gap
- +4%
- Target upside
- +17.8%
- High target gap
- +36.2%
- Target range width
- 32.2%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Teva Pharmaceutical Industries?
Teva Pharmaceutical Industries has a verified Strong Buy consensus. The same dataset has an average price target of $47.58.
How far are Teva Pharmaceutical Industries's low and high targets from the recorded price?
The low target implies +4%, while the high target implies +36.2%.
How many analysts are included in Teva Pharmaceutical Industries's consensus?
The verified consensus includes 12 analysts.
How is Teva Pharmaceutical Industries's target upside or downside calculated?
The average target of $47.58 is divided by the recorded price of $40.39, then one is subtracted to produce +17.8%. This does not guarantee a future return.
When was Teva Pharmaceutical Industries's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.